Dapagliflozin propanediol is used to improve blood sugar control in adults with type 2 diabetes. It helps reduce the risk of hospitalization for heart failure in people with type 2 diabetes and known cardiovascular disease or multiple cardiovascular risk factors. Additionally, it is used to lower the risk of cardiovascular death and hospitalization in adults
with heart failure and chronic kidney disease.